Multimodality imaging of prostate cancer Review

   


Authors: Ghafoor, S.; Burger, I. A.; Vargas, A. H.
Review Title: Multimodality imaging of prostate cancer
Abstract: Prostate cancer is a very heterogeneous disease, and contemporary management is focused on identification and treatment of the prognostically adverse high-risk tumors while minimizing overtreatment of indolent, low-risk tumors. In recent years, imaging has gained increasing importance in the detection, staging, posttreatment assessment, and detection of recurrence of prostate cancer. Several imaging modalities including conventional and functional methods are used in different clinical scenarios with their very own advantages and limitations. This continuing medical education article provides an overview of available imaging modalities currently in use for prostate cancer followed by a more specific section on the value of these different imaging modalities in distinct clinical scenarios, ranging from initial diagnosis to advanced, metastatic castration-resistant prostate cancer. In addition to established imaging indications, we will highlight some potential future applications of contemporary imaging modalities in prostate cancer. © 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Keywords: primary tumor; unclassified drug; cancer recurrence; cancer staging; positron emission tomography; lymph node metastasis; computer assisted tomography; distant metastasis; prostate cancer; prostate specific membrane antigen; fluorodeoxyglucose f 18; radiopharmaceutical agent; imaging; choline c 11; biochemical recurrence; bone scintiscanning; theranostics; castration resistant prostate cancer; psma; whole-body mri; pet/mri; sodium fluoride f 18; fluciclovine f 18; multiparametric magnetic resonance imaging; human; priority journal; article; multiparametric mri; positron emission tomography-computed tomography; fluciclovine; 18f 16beta fluoro 5alph dihydrotestosterone; positron emission tomography magnetic resonance imaging
Journal Title: Journal of Nuclear Medicine
Volume: 60
Issue: 10
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2019-10-01
Start Page: 1350
End Page: 1358
Language: English
DOI: 10.2967/jnumed.119.228320
PUBMED: 31481573
PROVIDER: scopus
PMCID: PMC6785785
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072849447&doi=10.2967%2fjnumed.119.228320&partnerID=40&md5=8138e21bf39f3d59220c807804b6c682
Notes: Source: Scopus -- Author Hebert Alberto Vargas's name is reversed on the original publication
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Hebert Alberto Vargas Alvarez
    267 Vargas Alvarez
  2. Soleen Ghafoor
    17 Ghafoor
Related MSK Work